GSK revises fiscal 2023 outlook following robust Q3 performance By Investing.com
© Reuters. GSK Plc, the British pharmaceutical giant, has revised its fiscal 2023 earnings and sales outlook upwards following a ...
© Reuters. GSK Plc, the British pharmaceutical giant, has revised its fiscal 2023 earnings and sales outlook upwards following a ...
© Reuters. FILE PHOTO: A woman exits the ground floor of an office building with Westpac logo amidst the easing ...
India is not a country of sticklers, by and large. It explains why the Union finance ministry’s economic review for ...
metamorworks MARKET OUTLOOK POSITIONING The fixed income investing landscape remained challenged in the third quarter. We maintain our recommendation for ...
© Reuters. Walgreens Boots Alliance, Inc. (NASDAQ:) announced on Thursday its fiscal year and Q4 results, revealing a net loss ...
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via EmailMatthew Graham, chief operating officer at Mortgage News ...
Receive free Global Economy updatesWe’ll send you a myFT Daily Digest email rounding up the latest Global Economy news every ...
Shares of Conagra Brands, Inc. (NYSE: CAG) stayed green on Tuesday. The stock has dropped 25% year-to-date and 15% over ...
AmyKerk/iStock via Getty Images Introduction Agenus (NASDAQ:AGEN), a clinical-stage firm, specializes in therapies utilizing the body's immune response to tackle ...
In this episode of EconTalk, Russ Roberts hosts Laurence Kotlikoff, a professor of economics at Boston University. Roberts and Kotlikoff ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.